Roche Pledges $50 Billion U.S. Investment To Expand Manufacturing And R&D As Trump Threatens Pharma Tariffs

Benzinga

Roche announced a $50 billion investment in the U.S. over the next five years, according to CNBC. The move aims to expand its manufacturing and R&D footprint amid tariff threats from President Donald Trump. The Swiss pharmaceutical company said its investment will create over 12,000 jobs, including 1,000 within the company and the rest tied to expanded U.S. manufacturing. The investment includes new facilities in Indiana, Pennsylvania, Massachusetts, and California, as well as a new manufacturing center to support its next-gen weight loss treatments.

Transcript

00:00It's Benzinga bringing Wall Street to Main Street.

00:02Roche announced a $50 million investment in the U.S. over the next five years, according to CNBC,

00:07moving to expand its manufacturing and R&D footprint amid terror threats for President

00:11Donald Trump. The Swiss pharmaceutical company said its investment will create over 12,000 jobs,

00:18including 1,000 within the company, and the rest tied to expanding U.S. manufacturing.

00:23The investment includes new facilities in Indiana, Pennsylvania, Massachusetts,

00:27and California, as well as a new manufacturing center to support its next-gen weight loss

00:32treatment. For all things money, visit Benzinga.com slash GSTV.

Category

Transcript

Comments

Recommended